Walgreens Boots Alliance completed the acquisition of the remaining 45% stake in CareCentrix for $392m.

Walgreens Boots Alliance, a retail drugstore, completed the acquisition of the remaining 45% stake in CareCentrix, a provider of ancillary care benefit management services, for $392m. “We continue to see strong results and potential for growth from our partnership with CareCentrix. Our full acquisition further accelerates our transformation to become a consumer-centric healthcare company, leveraging innovative platforms that extend our capabilities into fast-growing segments of healthcare. CareCentrix is key to offering services to our patients at every stage of the care continuum, and to driving long-term, sustainable growth as part of our US Healthcare strategy," Roz Brewer, WBA CEO.